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Abstract
This study was conducted on patients with thalassemia and HIV-infected patients to determine the frequency of diarrheagenic
Escherichia coli in Kerman, Iran. We analyzed 68 and 49 E coli isolates isolated from healthy fecal samples of patients with
thalassemia and HIV-infected patients, respectively. The E coli isolates were studied using a multiplex polymerase chain
reaction to identify the enterotoxigenic E coli (ETEC), enterohemorrhagic E coli (EHEC), and enteropathogenic E coli
(EPEC) groups. Statistical analysis was carried out to determine the correlation of diarrheagenic E coli between HIV-
infected patients and patients with thalassemia using Stata 11.2 software. The frequency of having at least 1 diarrheagenic
E coli was more common in patients with thalassemia (67.64%) than in HIV-infected patients (57.14%; P ¼ .25), including
ETEC (67.64% versus 57.14%), EHEC (33.82% versus 26.53%), and EPEC (19.11% versus 16.32%). The results of this study
indicate that ETEC, EHEC, and EPEC pathotypes are widespread among diarrheagenic E coli isolates in patients with
thalassemia and HIV-infected patients.
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Introduction
AIDS caused by the HIV is the most significant public health
issue in the world. The infection is alarming due to the patho-
genesis of the virus, which decreases the CD4 counts, enabling
the emergence of opportunistic infections in the host. Among
the opportunistic infections, gastrointestinal dysfunction has
been recognized as a major manifestation of HIV infection.1,2
Thalassemia is the most common single-gene disorder world-
wide and has seen the implementation of various successful
treatments, including blood transfusion, hematopoietic, man-
agement of deferoxamine, and cord blood stem cell transplan-
tation. Despite these treatment successes, infection is the
predominant cause of death.3 Diarrheagenic Escherichia coli
(DEC) pathotypes are one of the major etiological agents of
diarrhea in both developing and industrialized countries.4
Several types of DEC have been classified according to their
virulence traits, phenotypic assays, and serotypes including
enterotoxigenic E coli (ETEC), Shiga toxin-producing E coli
(STEC) or enterohemorrhagic E coli (EHEC), enteropatho-
genic E coli (EPEC), enteroinvasive E coli, enteroaggregative
E coli, and diffuse adherent E coli. Enterotoxigenic E coli is
the most common bacterial cause of diarrhea in all age groups
in regions with poor sanitation. This pathotype isolates cause
diarrhea by producing heat-stable (ST) and/or heat-labile (LT)
enterotoxins.5 Shiga toxin-producing E coli isolates are char-
acterized by the production of 2 potent cytotoxins including
Shiga-like toxin 1 (Stx1) and Shiga-like toxin 2 (Stx2). The
presence of the stx2 gene in the infecting isolate is associated
with severe disease in humans. In some STEC isolates, the
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presence of the eaeA gene, related to the intimate attachment
of bacteria to the host cell, is mediated by the binding of
intimin. The eaeA gene in STEC shares considerable
homology with the eaeA gene in EPEC.6,7 Characteristic
of EPEC isolates is the induction of attaching and effacing
(A/E) lesions on intestinal epithelial cells. The ability to pro-
duce A/E lesions is encoded by genes located on the locus
of enterocyte effacement, which contains the genes encoding
eae (intimin), the translocated intimin receptor, a number of
secreted proteins (E coli secretion protein), and a type III
secretion system.8
Our goal was to investigate the prevalence of the ETEC,
STEC, and atypical EPEC in HIV-infected patients and
patients with thalassemia. A further aim was to determine the
correlation of DEC between HIV-infected patients and patients
with thalassemia. To the best of our knowledge, this study is the




In this cross-sectional study, the HIV-positive patients were
studied at the Voluntary and Counseling Testing Center in Ker-
man, Iran. The HIV samples were from 43 males and 6 females.
We also surveyed patients with thalassemia at the Charity
Foundation for Special Diseases in Kerman, Iran. There were
42 males and 26 female patients. All fecal samples were
obtained from September to December 2014.
Bacteria
This study included 68 and 49 E coli isolates isolated from
healthy fecal samples of patients with thalassemia and HIV-
infected patients, respectively, in Kerman, Iran. Each sam-
ple was streaked on MacConkey agar and eosin–methylene
blue plates (Biolife Laboratories, Milan, Italy) and incubated
overnight at 37C. From each plate, 1 colony, detected as E
coli on the basis of its morphology, was inoculated in 5 mL
tryptic soy broth and incubated overnight at 37C. The over-
night bacterial culture was subjected to a biochemical API
20E identification system (BioMe´rieux, Marcy-l’E´toile,
France). Escherichia coli isolates were stored at 70C in
Luria-Bertani broth (Invitrogen, Paisley, Scotland) with 30%
glycerol for later use.
Polymerase Chain Reaction and DNA Extraction
DNA was extracted using the lysis method and was stored at
20C.9 Amplification of bacterial DNA was performed using
25 mL volumes containing 5 mL of the template DNA; 0.2
mmol/L of each deoxyadenosine triphosphate, deoxyguanosine
triphosphate, deoxycytidine triphosphate, and deoxythymidine
triphosphate; 1.5 mmol/L MgCl2; 1 reaction buffer; 0.5
mmol/L of each primer; and 1.2 U of Taq DNA polymerase
(CinnaGen Co, Karaj, Iran). The polymerase chain reaction
(PCR) products were electrophoresed via a 1.5% agarose gel
and visualized with an ultraviolet (UV) transilluminator after
ethidium bromide staining.
Identification of DEC Genes
For each isolate, a multiplex PCR assay was done to detect
the presence of genes LT and ST (ETEC)10 and genes stx1,
stx2, and eaeA (STEC and atypical EPEC).11 Escherichia
coli strain MG1655 was used as the negative control. Pos-
itive controls for PCR were E coli 10407 (STþ/LTþ) and E
coli Sakai (stx1þ/stx2þ/eaeAþ). The E coli strain MG1655
was used as a negative control for virulence genes. The ref-
erence strains were from the bacterial collection of the
Microbiology Department of E´cole Nationale Ve´te´rinaire
Toulouse, France. Details of the primers, the specific refer-
ence, and the length of the expected amplification product
are listed in Table 1.
Statistical Analysis
Data were described using descriptive statistics and 95%
confidence interval (CI). A w2 test was used to estimate the dif-
ference between different pathotypes (ETEC, EPEC, and
EHEC) and different health disorders (HIV and thalassemia).
A Mantel-Haenszel w2 statistic was used to estimate the corre-
lation of the presence of different genes after verifying the
health disorder and checking for interaction. Data management
and analysis were carried out using Stata 11.2 (StataCorp LP,
College Station, TX, USA).
Results
The PCR assay of 117 E coli isolates revealed that 74 isolates
(63.3%; 95% CI: 53.8-72.0) had at least one of the examined
virulence-related genes. The frequency of having at least 1
DEC was more common in patients with thalassemia (67.7%)
than in HIV-infected patients (57.2%), but there was no signif-
icant difference (P ¼ .25).
The ETEC pathotype was detected in 74 isolates (63.3%;
95% CI: 53.8-72.0); this pathotype was more common in
Table 1. Oligonucleotide Primers Used in this Study.
Gene Primer Sequence (50-30) Product Size (bp)
LT GGC GAC AGA TTA TAC CGT GC 450
CGG TCT CTA TAT TCC CTG TT
ST ATT TTT CTT TCT GTA TTG TCT T 190
CAC CCG GTA CAA GCA GGA TT
eaeA AGG CTT CGT CAC AGT TG 570
CCA TCG TCA CCA GAG GA
stx1 AGA GCG ATG TTA CGG TTT G 388
TTG CCC CCA GAG TGG ATG
stx2 TGG GTT TTT CTT CGG TAT C 807
GAC ATT CTG GTT GAC TCT CTT
Abbreviation: bp, base pair.
2 Journal of the International Association of Providers of AIDS Care
 by guest on November 21, 2015jia.sagepub.comDownloaded from 
patients with thalassemia (67.7%) compared to HIV-infected
patients (57.1%), but this difference was not significant (P ¼
.24). Of the 46 ETEC isolates from patients with thalassemia,
32 (69.7%) isolates were positive for ST gene, 3 (6.6%) isolates
were positive for LT gene, and 11 (23.9%) isolates showed both
ST and LT genes. Among 28 ETEC isolates from HIV-positive
patients, 21 (75.0%) isolates and 2 (7.2%) isolates were posi-
tive for ST and LT genes, respectively. Six (21.5%) isolates
from HIV samples possessed both ST and LT genes (Table 2
and Figure 1).
The prevalence of EHEC in total samples was 30.8
(95% CI: 25.6-40.0). Enterohemorrhagic E coli was more
frequent in patients with thalassemia than in HIV-infected
patients (33.9% versus 26.6%), but it was not significant
(P ¼ .4). The stx1 gene among EHEC genes was the most pre-
valent gene in both patient groups (29.1%). This gene was
detected in 32.4% and 24.5% of thalassemia and HIV isolates,
respectively. The Stx2 coding gene was detected in 1 isolate
from the patients with thalassemia. One of the isolates from
the HIV-infected patients produced both stx1 and stx2 genes
(Table 2 and Figure 2).
The prevalence of EPEC was 17.9% (95% CI: 11.5-26.1)
in all isolates. Of the 68 isolates examined from patients with
thalassemia, 13 (19.2%) isolates were positive for the atypical
EPEC pathotype coding genetic marker eaeA. The prevalence
of this gene in HIV-positive patients was 16.4% (Table 2).
There was no significant difference in the prevalence of EPEC
in HIV-infected patients and thalassemia (P ¼ .7). Several
combination patterns of the DEC genes were detected in iso-
lates (Table 3 and Figure 2).
Discussion
Infection is a major complication and the leading cause
of death in patients with thalassemia and HIV-infected
patients.12 According to a review by Wanachiwanawin in
Thailand, E coli was responsible for 26.0% of all severe infec-
tions in patients with thalassemia.12 Musiime et al13 found
that E coli, Salmonella, and Shigella species significantly
cause acute diarrhea in HIV-infected and HIV-uninfected
children in Uganda.
According to the results, DEC as a group were the most
common isolated pathogens in HIV-infected patients and
patients with thalassemia with healthy fecal matter. This
finding is similar to a study by Medina et al,14 in which
it was reported that the prevalence of DEC was the most
common pathogen in HIV-infected children with or without
diarrhea (19.0% versus 26.0%). The interpretation of patho-
gen frequency in healthy fecal matter is complicated. A high
frequency may be owing to host susceptibility to infection
and is determined by nutritional status, cell immunosuppres-
sion, prior exposure, and acquired immunity and/or genetic
susceptibility.
Enterotoxigenic E coli is related to 2 major clinical syn-
dromes: diarrhea among children in developing countries and
travelers’ diarrhea.15 In this study, ETEC was the most frequent
DEC in patients with thalassemia (*67%) but was also found in
HIV-infected patients (*57%). Ca´rcamo et al16 in Lima found
that 4% of the investigated HIV-infected patients with diarrhea
tested positive for ETEC. In a previous study of HIV-infected
Table 2. Distribution of Diarrheagenic Escherichia coli in HIV-Infected
Patients and Patients with Thalassemia.
DEC Gene Thalassemia, No (%) HIV, No (%) Total, No (%)
ETEC ST 32 (69.6) 21 (75.0) 53 (45.3)
LT 3 (6.6) 2 (7.2) 5 (4.3)
ST/LT 11 (23.9) 6 (21.5) 17 (14.6)
EHEC stx1 22 (32.4) 12 (24.5) 34 (29.1)
stx2 1 (1.5) – 1 (0.9)
stx1/stx2 – 1 (2.1) 1 (0.9)
EPEC eaeA 13 (19.2) 8 (16.4) 21 (17.9)
Abbreviations: DEC, Diarrheagenic E coli; EHEC, enterohemorrhagic E coli;
EPEC, enteropathogenic E coli; ETEC, enterotoxigenic E coli.
Figure 1. The multiplex polymerase chain reaction (PCR) results
for LT and ST genes. 1 indicates the marker 100 base pair (bp); 2, the
positive isolate for LT gene; 3, positive control Escherichia coli 10407; 4
and 6, the positive isolate for ST gene; 5, negative control E coliMG1655.
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infants from Zaire, ETEC was isolated in 11% of diarrhea
cases.17 Another study of HIV-infected children in Brazil
revealed that none of the isolates were positive for ETEC.18
Among patients with thalassemia, 33.4% had EHEC.
This pathogen was found in 26.6% of HIV-infected patients.
Enterohemorrhagic E coli isolates are a major cause of
gastroenteritis, which is in turn responsible for serious human
infections such as hemolytic uremic syndrome and hemorrha-
gic colitis.7 Previous studies showed discrepancies in the fre-
quency of STEC in different countries due to this pathogen not
being isolated from diarrhea samples.19,20 A survey of 158 iso-
lates obtained from HIV-positive patients with frequent watery
stools in Senegal showed that none of the isolates were positive
for STEC genes.21 In agreement with the results, Okeke et al22
reported the prevalence of STEC in 20.0% of acute diarrhea cases
in a study conducted in Nigeria. In this regard, Salmanzadeh-
Ahrabi et al23 showed that STEC is a significant cause of acute
diarrhea in Iran.
For many years, EPEC isolates have been known to be a
major pathogen in the pediatric population because of the high
morbidity and mortality rates, and now, this pathotype has
emerged as being significant enteropathogen in immunocom-
promised adults.21 The prevalence of EPEC in our study
(16.4%) was close to another report (15.0%) of HIV-infected
patients from Zaire.17 In a study of HIV-infected children less
than 13 years of age in Brazil, EPEC accounted for one isolate
among all the diarrhea cases.18 Previous studies in Brazil,24
Peru,25 and Australia26 reported that the prevalence of typical
EPEC isolates has decreased and that they are gradually being
replaced by atypical EPEC. This suggests that atypical EPEC is
an emerging diarrheagenic pathogen not only in developing but
also in industrialized countries.27 Asadi Karam et al28 in Iran
evaluated the presence of virulence genes in 321 E coli isolates
from children 5 years hospitalized with diarrhea and found
that 5.3% of the isolates possessed EPEC. In a study conducted
in Tehran, Iran, of patients referred to hospitals, there were 12
EPEC isolates isolated from acute diarrhea samples.29
The main limitation of this study is the small sample size of
patients. Other studies reflect low frequency of ETEC genes
(LT and ST) across the E coli isolates from HIV-infected
patients.16–18 However, findings of the current study indicated
high percentage of ETEC genes among HIV-infected patients
in Kerman, Iran. Environmental factors including poor sanita-
tion and fecal contamination of water and food may result in
frequent exposure to enteric pathogens in HIV-infected patients
and patients with thalassemia in developing countries. This
emphasizes the need to educate these patients about better
sanitation and personal hygiene and in using boiled or prop-
erly filtered water.
Conclusion
To our knowledge, this is the first study in which DEC iso-
lates were identified in healthy fecal samples from HIV-
infected patients and patients with thalassemia in Iran. The
results of this study indicate that DEC pathotypes such as
ETEC, EHEC, and EPEC were the most commonly isolated
enteropathogens in patients with thalassemia and HIV-
infected patients. Further studies of other DEC pathotypes
and genetic antibiotic-resistance patterns would be very use-
ful in evaluating the role of the different DEC pathotypes
and ultimately help in establishing new strategies to reduce
Figure 2. The multiplex polymerase chain reaction (PCR) results for
stx1, stx2, and eaeA genes. 1 indicates positive control Escherichia coli
Sakai; 2, the marker 100 base pair (bp); 3, negative control E coli
MG1655; 4, the positive isolate for stx2 gene; 5, the positive isolates
for stx1 and eaeA genes.
Table 3. Combination of Diarrheagenic Escherichia coli Genes in HIV-
Infected Patients and Patients with Thalassemia.
Gene Thalassemia, No (%) Gene HIV, No (%)
eaeA, ST, stx2 1 (1.5) LT, ST, stx1, stx2 1 (2.1)
eaeA, ST, stx1 6 (8.9) eaeA, ST, stx1 3 (6.2)
eaeA, LT, ST 1 (1.5) eaeA, LT, ST 1 (2.1)
LT, ST, stx1 2 (2.9) eaeA, stx1 3 (6.2)
eaeA, stx1 5 (7.4) stx1, ST 5 (10.2)
ST, stx1 8 (11.8) – –
Total 23 (33.9) 13 (26.6)
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morbidity and mortality related to infectious diseases in
HIV-infected patients and patients with thalassemia.
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